The DPP-4 inhibitors, which are oral antidiabetic drugs of a specific class, have now become one of the main therapeutic categories for T2D
A protective effect of GLP-1 agonists on blood vessels has been demonstrated, as evidenced by the reduction of non-fatal and fatal stroke incidence by 15% and 19%, respectively, in patients with T2DM treated with GLP-1 agonists [43]
Scientific References: Dou Y, Lee A, Zhu L, Morton J, Ladiges W., Aging Pathobiology and Therapeutics , 2020
Excess body weight: Novel insights into its roles in obesity comorbidities
I feel light physically and light mentally. The retired tennis pro explained that she decided to try weight-loss medication because she was never able to reach the weight she needed after giving birth to daughter Olympia in 2017